What Happened to Jayanta "Jay" Bhattacharya?
Jay Bhattacharya is an American health economist and physician who gained prominence for his critical stance on COVID-19 lockdowns and co-authorship of the Great Barrington Declaration in 2020. Since 2025, he has served as the 18th Director of the National Institutes of Health (NIH) and, as of February 2026, also holds the position of Acting Director of the Centers for Disease Control and Prevention (CDC) under the Trump administration, where he has influenced policy on research funding and gender-affirming care.
Quick Answer
Jay Bhattacharya is currently the 18th Director of the National Institutes of Health (NIH), a position he assumed on April 1, 2025, after being nominated by President Donald Trump and confirmed by the U.S. Senate. In a significant development in February 2026, he was also appointed as the Acting Director of the Centers for Disease Control and Prevention (CDC), concurrently holding both leadership roles in the Trump administration's health agencies. He continues to shape national health policy, notably advocating for conservative views on research funding and gender-affirming care, and has been actively involved in promoting NIH-funded research initiatives as recently as August 2026.
📊Key Facts
📅Complete Timeline13 events
Born in Kolkata, India
Jayanta Bhattacharya was born in Kolkata, India.
Earns MD and PhD from Stanford University
Bhattacharya completed his Doctor of Medicine (M.D.) from Stanford University School of Medicine in 1997 and his Ph.D. in economics from Stanford in 2000.
Joins Stanford University Faculty
Bhattacharya began his tenure as a Professor of Medicine at Stanford University, where he also held courtesy appointments in economics and health research and policy.
Co-authors Great Barrington Declaration
Bhattacharya, along with Martin Kulldorff and Sunetra Gupta, published the Great Barrington Declaration, advocating for 'focused protection' against COVID-19 and opposing lockdowns.
Nominated as NIH Director
President Donald Trump announced his nomination of Jay Bhattacharya as the 18th Director of the National Institutes of Health.
Confirmed as NIH Director by Senate
The U.S. Senate confirmed Bhattacharya's nomination as NIH Director in a party-line vote of 53 to 47.
Assumes Office as NIH Director
Jay Bhattacharya officially began his term as the 18th Director of the National Institutes of Health.
Implements new NIH subcontracting policy
As NIH Director, Bhattacharya eliminated subcontracting with foreign researchers, requiring direct contracts with the NIH instead.
Appointed Acting Director of CDC
Bhattacharya was concurrently appointed Acting Director of the Centers for Disease Control and Prevention, taking on a dual leadership role in the Trump administration.
Speaks at CPAC USA 2026
Bhattacharya was a confirmed speaker at the Conservative Political Action Conference (CPAC) USA 2026 in Grapevine, Texas.
Headlines NORD Rare Disease Scientific Symposium
Dr. Jay Bhattacharya delivered remarks at the second annual NORD Rare Disease Scientific Symposium, emphasizing the urgency of accelerating rare disease research.
Announces new policy on high-risk research
HHS, under Bhattacharya's leadership, released a new government-wide policy to end dangerous high-risk research.
Highlights NIH-funded cancer research
Bhattacharya shared news on X (formerly Twitter) about an NIH-funded international research team cataloging 25 tumor types to advance precision cancer research.
Follow this story
Get an email when this timeline gets a major update.
🔍Deep Dive Analysis
Jayanta "Jay" Bhattacharya, born in 1968 in Kolkata, India, is a distinguished American health economist and physician, holding multiple degrees from Stanford University, including an M.D. and a Ph.D. in economics. Prior to his federal appointments, he was a professor of medicine, economics, and health research policy at Stanford University, where his research focused on the economics of healthcare and the well-being of vulnerable populations. He also directed Stanford's Center for Demography and Economics of Health and Aging.
Bhattacharya rose to international prominence during the COVID-19 pandemic as a vocal critic of widespread lockdown measures. In October 2020, he co-authored the controversial Great Barrington Declaration alongside Martin Kulldorff and Sunetra Gupta. This open letter advocated for a strategy of "focused protection," shielding vulnerable populations while allowing the virus to spread among healthier individuals to achieve herd immunity, a position that diverged significantly from mainstream public health consensus at the time. The declaration sparked considerable debate and was opposed by many public health bodies, including the World Health Organization.
His career took a significant turn in November 2024 when President Donald Trump nominated him to lead the National Institutes of Health (NIH). Following Senate confirmation on March 25, 2025, Bhattacharya officially became the 18th Director of the NIH on April 1, 2025, becoming the first Indian American to hold the position. In this role, he has pursued policies aligned with conservative viewpoints, including withholding research grants from institutions not adhering to specific ideological stances and eliminating subcontracting with foreign researchers. He also championed a Trump administration report that made it illegal for the federal government to advocate for gender-affirming care for individuals under 19, instead promoting conversion therapy, a move that contradicted the consensus of the mainstream medical community.
Further consolidating his influence within the Trump administration's health apparatus, Bhattacharya was appointed Acting Director of the Centers for Disease Control and Prevention (CDC) on February 18, 2026, while retaining his NIH directorship. This dual role has drawn scrutiny, with some observers expressing concerns about the potential for further consolidation of power and shifts in public health policy, particularly regarding vaccine schedules, given his close ties to HHS Secretary Robert F. Kennedy Jr. Despite these criticisms, Bhattacharya has remained active in his leadership roles, speaking at events like CPAC USA 2026 in March 2026 and the NORD Rare Disease Scientific Symposium in April 2026. As of August 2026, he continues to lead both the NIH and CDC, promoting initiatives such as NIH-funded cancer research and discussing national biomedical priorities.
What If...?
Explore alternate histories. What if Jayanta "Jay" Bhattacharya made different choices?